Cadence Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-33,605
| Closed | -$1.09M | – | 288 |
|
|
2020
Q2 | $1.09M | Buy |
33,605
+1,437
| +4% | +$46.5K | 0.16% | 201 |
|
|
2020
Q1 | $1.31M | Sell |
32,168
-2,180
| -6% | -$88.8K | 0.22% | 135 |
|
|
2019
Q4 | $2.12M | Sell |
34,348
-5,655
| -14% | -$349K | 0.23% | 117 |
|
|
2019
Q3 | $2.92M | Sell |
40,003
-281
| -0.7% | -$20.5K | 0.41% | 64 |
|
|
2019
Q2 | $3.31M | Sell |
40,284
-20,346
| -34% | -$1.67M | 0.33% | 64 |
|
|
2019
Q1 | $4.28M | Buy |
60,630
+583
| +1% | +$41.1K | 0.38% | 52 |
|
|
2018
Q4 | $2.7M | Buy |
60,047
+4,663
| +8% | +$210K | 0.27% | 96 |
|
|
2018
Q3 | $3.13M | Buy |
55,384
+9,276
| +20% | +$524K | 0.17% | 152 |
|
|
2018
Q2 | $3.08M | Buy |
46,108
+20,947
| +83% | +$1.4M | 0.18% | 126 |
|
|
2018
Q1 | $1.47M | Buy |
25,161
+835
| +3% | +$48.6K | 0.1% | 301 |
|
|
2017
Q4 | $1.57M | Sell |
24,326
-9,076
| -27% | -$585K | 0.1% | 270 |
|
|
2017
Q3 | $1.75M | Buy |
33,402
+27,005
| +422% | +$1.42M | 0.11% | 220 |
|
|
2017
Q2 | $299K | Buy |
6,397
+345
| +6% | +$16.1K | 0.02% | 602 |
|
|
2017
Q1 | $300K | Sell |
6,052
-2,440
| -29% | -$121K | 0.02% | 608 |
|
|
2016
Q4 | $515K | Sell |
8,492
-8,337
| -50% | -$506K | 0.04% | 499 |
|
|
2016
Q3 | $1.12M | Sell |
16,829
-112
| -0.7% | -$7.43K | 0.08% | 284 |
|
|
2016
Q2 | $946K | Buy |
16,941
+554
| +3% | +$30.9K | 0.07% | 301 |
|
|
2016
Q1 | $552K | Buy |
16,387
+9,060
| +124% | +$305K | 0.04% | 455 |
|
|
2015
Q4 | $331K | Sell |
7,327
-497
| -6% | -$22.5K | 0.02% | 534 |
|
|
2015
Q3 | $309K | Sell |
7,824
-2,340
| -23% | -$92.4K | 0.02% | 521 |
|
|
2015
Q2 | $631K | Sell |
10,164
-6,456
| -39% | -$401K | 0.04% | 498 |
|
|
2015
Q1 | $1.04M | Buy |
+16,620
| New | +$1.04M | 0.06% | 398 |
|